Skip to content

Understanding the use of the MEPP 2.0 website in facial rehabilitation

Implantation and development of the technosocial webtool MEPP 2.0 for facial rehabilitation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10885397
Enrollment
56
Registered
2023-01-12
Start date
2023-01-16
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial rehabilitation in patients with facial palsy Nervous System Diseases

Interventions

The MEPP for rehabilitation of peripheral facial palsy The MEPP is based on relevant components from two existing facial rehabilitation protocols: The Mirror Effect Protocol and the Neuromuscular Retr

Sponsors

Hôpital Maisonneuve-Rosemont
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with facial paralysis: 1. Aged 18 years old and over 2. Suffer from peripheral facial paralysis 3. Have used or agreed to use the MEPP 1.0 and the MEPP 2.0 in the clinic or during a standardized trial to obtain enlightened comparative impressions of the two tools 4. Speak and read enough French and/or English to be able to answer an interview and standardized questionnaire. Clinicians working with customers with facial paralysis: 1. Aged 18 years and over 2. Having used the MEPP 1.0 and the MEPP 2.0 in the clinic or during a standardized trial allowing to obtain comparative impressions enlightened on the two tools 3. Speak and read French and/or English enough to be able to answer an interview and standardized questionnaire

Exclusion criteria

Exclusion criteria: Patients: Not have a major cognitive impairment that interferes with the ability to answer the questionnaires and interview questions of this project, as assessed by a score higher than 27 on the Montreal Cognitive Assessment (MoCA)

Design outcomes

Primary

MeasureTime frame
User experience of clinicians and patients with website MEPP 2.0 and with MEPP 1.0 (crossover) measured using the standardized MeCUE questionnaire after 2 to 4 weeks of use for each website

Secondary

MeasureTime frame
1. Adherence to treatment for patients measured using the number of completed sessions recorded by the websites after 2 to 4 weeks of use for each website 2. Embodiment for patients measured using the standardized Virtual Embodiment Questionnaire (VEQ) after 2 to 4 weeks of use for each website 3. Modulating factors of clinical practice for clinicians measured using standardized interviews after 2 to 4 weeks of use for each website

Countries

Canada

Contacts

Public ContactJacinthe Barbeau
jacinthe.barbeau.ccsmtl@ssss.gouv.qc.ca+1 514-284-2214 3426

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 6, 2026